Skip to main content
Clinical Trials/CTRI/2020/03/023790
CTRI/2020/03/023790Not yet recruitingPhase 2

Efficacy of Jawarish Shahi in Irritable Bowel Syndrome â?? An Open Labelled Interventional Clinical Trial

ational Institute of Unani Medicine0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 2
Status
Not yet recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • 1.Clinically diagnosed cases of IBS according to ROME-4 criteria
  • 2.Patients who will give consent and able to do follow up

Exclusion Criteria

  • 1.Patients suffering from systemic illness like Hypertension, DM, Malignancy, Liver or Kidney dysfunction
  • 2.Patients suffering from IBD (Ulcerative colitis, Crohnâ??s disease), Amoebic dysentery, Intestinal tuberculosis or Intestinal obstruction
  • 3.Patients below 18 and above 50 years
  • 4.Pregnant and lactating women

Investigators

Sponsor
ational Institute of Unani Medicine

Similar Trials